HIV Treatment Bulletin - Vol. 5, No. 7, August/September 2004

The US Food and Drug Administration has approved two antiretroviral drug combinations made by GlaxoSmithKline and Gilead Sciences for use in the United States and in developing countries. Truvada, the Gilead medicine, contains emtricitabine and tenofovir. Epzicom, the Glaxo combination, contains lamivudine and abacavir.

The speedy approval time - only four months for Truvada - confirms speculation that US regulations would facilitate rapid approval for brand name drugs so they can be bought with PEPFAR (the $15 billion President’s Emergency Plan for AIDS Relief) dollars in developing countries. Observers are waiting to see if generic drugs are approved as quickly or if, as is expected, they will be held up by the American bureaucracy in order to favour the multinational pharmaceutical companies.

The US price for Truvada is $650.83 and Epzicom is $621.60 for 30-day supplies.

Source: FDA press release
http://www.fda.gov/bbs/topics/news/2004/NEW01099.html

040810
IB040507-23

©2004. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.